Universität zu Köln

Fischer, Matthias, Moreno, Lucas, Ziegler, David S., Marshall, Lynley, V, Zwaan, C. Michel, Irwin, Meredith S., Casanova, Michela, Sabado, Constantino, Wulff, Beate, Stegert, Mario, Wang, Luojun, Hurtado, Felipe K., Branle, Fabrice, Geoerger, Birgit and Schulte, Johannes H. (2021). Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study. Lancet Oncol., 22 (12). S. 1764 - 1777. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Geoerger, Birgit, Bourdeaut, Franck, DuBois, Steven G., Fischer, Matthias, Geller, James I., Gottardo, Nicholas G., Marabelle, Aurelien, Pearson, Andrew D. J., Modak, Shakeel ORCID: 0000-0002-7280-1726, Cash, Thomas, Robinson, Giles W., Motta, Marlyane, Matano, Alessandro, Bhansali, Suraj G., Dobson, Jason R., Parasuraman, Sudha and Chi, Susan N. (2017). A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors. Clin. Cancer Res., 23 (10). S. 2433 - 2442. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

Moreno, Lucas, Barone, Giuseppe, DuBois, Steven G., Molenaar, Jan, Fischer, Matthias, Schulte, Johannes, Eggert, Angelika ORCID: 0000-0003-3476-8184, Schleiermacher, Gudrun, Speleman, Frank, Chesler, Louis, Geoerger, Birgit, Hogarty, Michael D., Irwin, Meredith S., Bird, Nick, Blanchard, Guy B., Buckland, Sean, Caron, Hubert, Davis, Susan, De Wilde, Bram, DeubZer, Hedwig E., Dolman, Emmy, Eilers, Martin, George, Rani E., George, Sally, Sterba, Jaroslav, Maris, John M., Marshall, Lynley, Merchant, Melinda, Mortimer, Peter, Owens, Cormac, Philpott, Anna, Poon, Evon, Shay, Jerry W., Tonelli, Roberto, Valteau-Couanet, Dominique, Vassal, Gilles, Park, Julie R. and Pearson, Andrew D. J. (2020). Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma. Eur. J. Cancer, 136. S. 52 - 69. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Moreno, Lucas ORCID: 0000-0002-0708-1670, Caron, Hubert, Geoerger, Birgit, Eggert, Angelika, Schleiermacher, Gudrun, Brock, Penelope, Valteau-Couanet, Dominique, Chesler, Louis ORCID: 0000-0001-7842-2068, Schulte, Johannes H., De Preter, Katleen, Molenaar, Jan, Schramm, Alexander ORCID: 0000-0001-7670-7529, Eilers, Martin, Van Maerken, Tom, Johnsen, John Inge, Garrett, Michelle, George, Sally L., Tweddle, Deborah A., Kogner, Per ORCID: 0000-0002-2202-9694, Berthold, Frank, Koster, Jan ORCID: 0000-0002-0890-7585, Barone, Giuseppe, Tucker, Elizabeth R., Marshall, Lynley, Herold, Ralf ORCID: 0000-0002-8148-6748, Sterba, Jaroslav, Norga, Koen, Vassal, Gilles and Pearson, Andrew D. J. (2017). Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project. Expert. Opin. Drug Discov., 12 (8). S. 801 - 812. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1746-045X

Schulte, Johannes H., Moreno, Lucas, Ziegler, David Simon, Marshall, Lynley V., Zwaan, C. Michel, Irwin, Meredith, Casanova, Michela, Sabado, Constantino, Wulff, Beate, Stegert, Mario, Wang, Luojun, Hurtado, Felipe K., Branle, Fabrice, Fischer, Matthias and Geoerger, Birgit (2020). Final analysis of phase I study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK). J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755